{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:43:14Z","timestamp":1768074194142,"version":"3.49.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12016-015-8513-8","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T08:07:20Z","timestamp":1444378040000},"page":"45-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Clinical Features of Myositis-Associated Autoantibodies: a Review"],"prefix":"10.1007","volume":"52","author":[{"given":"Harsha","family":"Gunawardena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,9]]},"reference":[{"issue":"7","key":"8513_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"8513_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"4","key":"8513_CR3","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, Sato T, Kiuchi T, Ohashi Y (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22(4):668\u2013674","journal-title":"J Rheumatol"},{"issue":"6","key":"8513_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2009) Myositis specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 48(6):607\u2013612","journal-title":"Rheumatology"},{"issue":"3","key":"8513_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","volume":"47","author":"S Tansley","year":"2014","unstructured":"Tansley S, Gunawardena H (2014) The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47(3):264\u2013273","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"8513_CR6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14397595.2014.896494","volume":"24","author":"EH Kang","year":"2014","unstructured":"Kang EH, Kuwana M, Okazaki Y, Lee EY, Lee YJ, Lee EB et al (2014) Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients. Mod Rheumatol 24(6):945\u2013948","journal-title":"Mod Rheumatol"},{"issue":"1","key":"8513_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","volume":"9","author":"J Ronnelid","year":"2009","unstructured":"Ronnelid J, Barbasso Helmers S, Storfors H, Grip K, Ronnblom L, Franck-Larsson K et al (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9(1):58\u201361","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8513_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085062","volume":"9","author":"R Nakashima","year":"2014","unstructured":"Nakashima R, Imura Y, Hosono Y, Seto M, Murakami A, Watanabe K et al (2014) The multicenter study of a New assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS ONE 9(1), e85062","journal-title":"PLoS ONE"},{"key":"8513_CR9","doi-asserted-by":"crossref","unstructured":"Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C et al. (2014) Anti-signal recognition particle autoantibody ELISA validation and clinical associations. Rheumatology Dec 17 pii: keu436 [Epub ahead of print]","DOI":"10.1093\/rheumatology\/keu436"},{"key":"8513_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cca.2014.01.005","volume":"431","author":"H Hane","year":"2014","unstructured":"Hane H, Muro Y, Watanabe K, Ogawa Y, Sugiura K, Akiyama M (2014) Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis\/polymyositis and interstitial lung disease. Clin Chim Acta 431:9\u201314","journal-title":"Clin Chim Acta"},{"issue":"7","key":"8513_CR11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60(7):2193\u20132200","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8513_CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/ket383","volume":"53","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C et al (2014) Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation. Rheumatology 53(3):433\u2013437","journal-title":"Rheumatology"},{"issue":"6","key":"8513_CR13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2011-200871","volume":"71","author":"M Labrador-Horrillo","year":"2012","unstructured":"Labrador-Horrillo M, Martinez MA, Selva-O\u2019Callaghan A et al (2012) Anti-TIF1 antibodies (antip155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis 71(6):993\u2013996","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8513_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","volume":"51","author":"A Ishikawa","year":"2012","unstructured":"Ishikawa A, Muro Y, Sugiura K, Akiyama M (2012) Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology 51(7):1181\u20131187","journal-title":"Rheumatology"},{"key":"8513_CR15","doi-asserted-by":"crossref","first-page":"856815","DOI":"10.1155\/2013\/856815","volume":"2013","author":"Y Muro","year":"2013","unstructured":"Muro Y, Sugiura K, Akiyama M (2013) A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement. Clin Dev Immunol 2013:856815","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"8513_CR16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721","journal-title":"Arthritis Rheum"},{"key":"8513_CR17","first-page":"405956","volume":"2014","author":"L Musset","year":"2014","unstructured":"Musset L, Miyara M, Benveniste O, Charuel J-L, Shikhman A, Boyer O et al (2014) Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies. Int J Immunol Res 2014:405956","journal-title":"Int J Immunol Res"},{"issue":"1","key":"8513_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4468","volume":"16","author":"L Drouot","year":"2014","unstructured":"Drouot L, Allenbach Y, Jouen F, Charuel J-L, Martinet JRM, Meyer A et al (2014) Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3- methyl-glutaryl-CoA reductase autoantibodies. Arthritis Res Ther 16(1):1\u201311","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8513_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26(1):459\u2013467","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8513_CR20","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","volume":"135","author":"M Kalluri","year":"2009","unstructured":"Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK et al (2009) Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature. Chest 135(6):1550\u20131556","journal-title":"Chest"},{"issue":"1","key":"8513_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35\u201342","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"8513_CR22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejrad.2014.11.026","volume":"84","author":"MP Debray","year":"2015","unstructured":"Debray MP, Borie R, Revel MP, Naccache JM, Khalil A, Toper C et al (2015) Interstitial lung disease in anti-synthetase syndrome: initial and follow up CT findings. Eur J Radiol 84(3):516\u2013523","journal-title":"Eur J Radiol"},{"issue":"1","key":"8513_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acr.22394","volume":"67","author":"A Fischer","year":"2015","unstructured":"Fischer A, Brown KK (2015) Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res 67(1):4\u201311","journal-title":"Arthritis Care Res"},{"issue":"282","key":"8513_CR24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","volume":"77","author":"C Marguerie","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77(282):1019\u20131038","journal-title":"Q J Med"},{"issue":"2","key":"8513_CR25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0034-1371528","volume":"35","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Ascherman DP, Danoff SK (2014) Pulmonary manifestations of polymyositis\/dermatomyositis. Semin Respir Crit Care Med 35(2):239\u2013248","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"8513_CR26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/BOR.0000000000000104","volume":"26","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Danoff SK (2014) Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. Curr Opin Rheumatol 26(6):684\u2013689","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"8513_CR27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","volume":"105","author":"K Watanabe","year":"2011","unstructured":"Watanabe K, Handa T, Tanizawa K, Hosono Y, Taguchi Y, Noma S et al (2011) Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 105(8):1238\u20131472","journal-title":"Respir Med"},{"issue":"8","key":"8513_CR28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jclinpath-2014-202367","volume":"67","author":"F Schneider","year":"2014","unstructured":"Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R (2014) Pulmonary pathologic manifestations of anti-glycl-tRNA synthetase (anti-EJ)- related inflammatory myopathy. J Clin Pathol 67(8):678\u2013683","journal-title":"J Clin Pathol"},{"issue":"5","key":"8513_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","volume":"24","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P et al (2013) Clinical manifestations and outcome of anti-PL7 positive patients with anti-synthetase syndrome. Eur J Intern Med 24(5):474\u2013479","journal-title":"Eur J Intern Med"},{"issue":"10","key":"8513_CR30","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","volume":"108","author":"C Johnson","year":"2014","unstructured":"Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B et al (2014) Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type. Respir Med 108(10):1542\u20131548","journal-title":"Respir Med"},{"issue":"6","key":"8513_CR31","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.lpm.2012.12.003","volume":"42","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Landron C, Roblot P et al (2013) Outcome of anti-PL12 positive patients with antisynthetase syndrome. Presse Med 42(6):e153\u2013e158","journal-title":"Presse Med"},{"issue":"10","key":"8513_CR32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11(10):739\u2013745","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8513_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M et al (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8(4), e60442","journal-title":"PLoS One"},{"key":"8513_CR34","unstructured":"Lefevre G, Meyer A, Launay D, Machelart I, DeBandt M, Michaud J et al (2014) Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients. Rheumatology 27"},{"issue":"5","key":"8513_CR35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571\u20131576","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8513_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65(1):25\u201334","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8513_CR37","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C et al (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 16(4):R138","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"8513_CR38","first-page":"891","volume":"32","author":"A Ceribelli","year":"2014","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C et al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol 32(6):891\u2013897","journal-title":"Clin Exp Rheumatol"},{"key":"8513_CR39","first-page":"290797","volume":"2014","author":"M Labrador-Horrillo","year":"2014","unstructured":"Labrador-Horrillo M, Martinez MA, Selva-O\u2019Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, Ju\u00e1rez C (2014) Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. Int J Immunol Res 2014:290797","journal-title":"Int J Immunol Res"},{"issue":"9","key":"8513_CR40","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K et al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 49(9):1713\u20131719","journal-title":"Rheumatology"},{"issue":"9","key":"8513_CR41","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y et al (2012) Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology 51(9):1563\u20131567","journal-title":"Rheumatology"},{"issue":"4","key":"8513_CR42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","volume":"91","author":"NF Chaisson","year":"2012","unstructured":"Chaisson NF, Paik J, Orbai AM, Casciola-Rosen L, Fiorentino D, Danoff S, Rosen A (2012) A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine (Baltimore) 91(4):220\u2013228","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"8513_CR43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L (2013) Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res 65(8):1307\u20131315","journal-title":"Arthritis Care Res"},{"issue":"4","key":"8513_CR44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","volume":"158","author":"I Kobayashi","year":"2011","unstructured":"Kobayashi I, Okura Y, Yamada M, Kawamura N, Kuwana M, Ariga T (2011) Anti-melanoma differentiation -associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis. J Pediatr 158(4):675\u2013677","journal-title":"J Pediatr"},{"key":"8513_CR45","doi-asserted-by":"crossref","unstructured":"Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K et al (2014) Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology","DOI":"10.1093\/rheumatology\/keu385"},{"issue":"4","key":"8513_CR46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","volume":"60","author":"R Aggarwal","year":"2009","unstructured":"Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr (2009) Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 60(4):1112\u20131118","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8513_CR47","first-page":"S12","volume":"30","author":"RW Koschik 2nd","year":"2012","unstructured":"Koschik RW 2nd, Fertig N, Lucas MR, Domsic RT, Medsger TA Jr (2012) Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 30(2):S12\u2013S16","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"8513_CR48","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","volume":"66","author":"J D\u2019Aoust","year":"2014","unstructured":"D\u2019Aoust J, Hudson M, Tatibouet S, Wick J, Canadian Scleroderma Research Group, Mahler M, Baron M, Fritzler MJ (2014) Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheum 66(6):1608\u20131615","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8513_CR49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3899\/jrheum.090652","volume":"37","author":"JC Lega","year":"2010","unstructured":"Lega JC, Cottin V, Fabien N, Thivolet-B\u00e9jui F, Cordier JF (2010) Interstitial lung disease associated with anti-PM\/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? J Rheumatol 37(5):1000\u20131009","journal-title":"J Rheumatol"},{"issue":"1","key":"8513_CR50","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","volume":"11","author":"K Hanke","year":"2009","unstructured":"Hanke K, Br\u00fcckner CS, D\u00e4hnrich C, Huscher D, Komorowski L, Meyer W et al (2009) Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 11(1):R22","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8513_CR51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.semarthrit.2014.07.002","volume":"44","author":"A Guillen-Del Castillo","year":"2014","unstructured":"Guillen-Del Castillo A, Pilar Sime\u00f3n-Aznar C, Fonollosa-Pla V, Alonso-Vila S, Reverte-Vinaixa MM, Mu\u00f1oz X et al (2014) Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM\/Scl antibody. Semin Arthritis Rheum 44(3):331\u2013337","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"8513_CR52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780390712","volume":"39","author":"FC Arnett","year":"1996","unstructured":"Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, Leroy EC, Fritzler MJ (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 39(7):1151\u20131160","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8513_CR53","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","volume":"40","author":"VJ Tormey","year":"2001","unstructured":"Tormey VJ, Bunn CC, Denton CP, Black CM (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology 40(10):1157\u20131162","journal-title":"Rheumatology"},{"issue":"4","key":"8513_CR54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","volume":"66","author":"K Kaji","year":"2014","unstructured":"Kaji K, Fertig N, Medsger TA Jr, Satoh T, Hoshino K, Hamaguchi Y et al (2014) Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res 66(4):575\u2013584","journal-title":"Arthritis Care Res"},{"issue":"2","key":"8513_CR55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","volume":"16","author":"JM Olazagasti","year":"2015","unstructured":"Olazagasti JM, Baez PJ, Wetter DA, Ernste FC (2015) Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol 16(2):89\u201398","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"8513_CR56","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66(10):1345\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8513_CR57","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54(11):3682\u20133689","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8513_CR58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y et al (2007) Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 46(1):25\u201328","journal-title":"Rheumatology"},{"issue":"1","key":"8513_CR59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Aragu\u00e1s","year":"2010","unstructured":"Trallero-Aragu\u00e1s E, Labrador-Horrillo M, Selva-O\u2019Callaghan A, Mart\u00ednez MA, Mart\u00ednez-G\u00f3mez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarr\u00e9s M (2010) Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) 89(1):47\u201352","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"8513_CR60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M et al (2012) Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 64(2):513\u2013522","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8513_CR61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s E, Rodrigo-Pend\u00e1s J\u00c1, Selva-O\u2019Callaghan A, Mart\u00ednez-G\u00f3mez X, Bosch X, Labrador-Horrillo M, Grau-Junyent JM, Vilardell-Tarr\u00e9s M (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64(2):523\u2013532","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8513_CR62","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/BOR.0b013e32833f1075","volume":"22","author":"A Selva-O\u2019Callaghan","year":"2010","unstructured":"Selva-O\u2019Callaghan A, Trallero-Aragu\u00e1s E, Grau-Junyent JM, Labrador-Horrillo M (2010) Malignancy and myositis: novel autoantibodies and new insights. Curr Opin Rheumatol 22(6):627\u2013632","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"8513_CR63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","volume":"72","author":"DF Fiorentino","year":"2015","unstructured":"Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis. J Am Acad Dermatol 72(3):449\u2013455","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"8513_CR64","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, Rosen A, Casciola-Rosen L (2013) Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum 65(11):2954\u20132962","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8513_CR65","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y et al (2012) Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71(5):710\u2013713","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8513_CR66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H et al (2008) Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology 47(3):324\u2013328","journal-title":"Rheumatology"},{"issue":"2","key":"8513_CR67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","volume":"87","author":"A Bingham","year":"2008","unstructured":"Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A et al (2008) Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) 87(2):70\u201386","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"8513_CR68","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","volume":"36","author":"G Espada","year":"2009","unstructured":"Espada G, Maldonado Cocco JA, Fertig N, Oddis CV (2009) Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol 36(11):2547\u20132551","journal-title":"J Rheumatol"},{"issue":"6","key":"8513_CR69","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE et al (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60(6):1807\u20131814","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8513_CR70","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","volume":"53","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, McHugh NJ, Juvenile Dermatomyositis Research Group (2014) Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology 53(12):2204\u20132208","journal-title":"Rheumatology"},{"issue":"7","key":"8513_CR71","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"A Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L, Fiorentino D (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150(7):724\u2013729","journal-title":"JAMA Dermatol"},{"issue":"2","key":"8513_CR72","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M et al (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14(2):R97","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8513_CR73","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.jaad.2012.01.015","volume":"67","author":"K Sugiura","year":"2012","unstructured":"Sugiura K, Muro Y, Akiyama M (2012) Autoantibodies to nuclear matrix protein 2\/MJ in adult-onset dermatomyositis with severe calcinosis. J Am Acad Dermatol 67(4):e167\u2013e168","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8513_CR74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/art.38928","volume":"67","author":"AA Shah","year":"2015","unstructured":"Shah AA, Casciola-Rosen L, Rosen A (2015) Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheum 67(2):317\u2013326","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8513_CR75","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ, UK Adult Onset Myositis Immunogenetic Collaboration (2009) Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis 68(10):1621\u20131625","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"8513_CR76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","volume":"384","author":"E Tarricone","year":"2012","unstructured":"Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A (2012) Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 384(1\u20132):128\u2013134","journal-title":"J Immunol Methods"},{"issue":"4","key":"8513_CR77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08916934.2012.755958","volume":"46","author":"Y Muro","year":"2013","unstructured":"Muro Y, Sugiura K, Akiyama M (2013) Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 46(4):279\u2013284","journal-title":"Autoimmunity"},{"issue":"12","key":"8513_CR78","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6ll\u0151si L, Dank\u00f3 K (2014) Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 13(12):1211\u20131219","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8513_CR79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","volume":"72","author":"M Fujimoto","year":"2013","unstructured":"Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F et al (2013) Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 72(1):151\u2013153","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8513_CR80","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28(7):796\u2013803","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8513_CR81","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/art.11090","volume":"48","author":"S Okada","year":"2003","unstructured":"Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW, International Myositis Collaborative Study Group (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48(8):2285\u20132293","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8513_CR82","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","volume":"60","author":"LA Love","year":"2009","unstructured":"Love LA, Weinberg CR, McConnaughey DR, Oddis CV, Medsger TA Jr, Reveille JD, Arnett FC, Targoff IN, Miller FW (2009) Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum 60(8):2499\u20132504","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8513_CR83","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar4207","volume":"4;15","author":"MH Petri","year":"2013","unstructured":"Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ram\u00edrez R, Jara LJ, Saavedra MA et al (2013) Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther 4;15(2):R48","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8513_CR84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW, Childhood Myositis Heterogeneity Collaborative Study Group (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92(4):223\u2013243","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"8513_CR85","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1073\/pnas.81.6.1674","volume":"81","author":"DA Brown","year":"1984","unstructured":"Brown DA, Simoni RD (1984) Biogenesis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, an integral glycoprotein of the endoplasmic reticulum. Proc Natl Acad Sci U S A 81(6):1674\u20131678","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"8513_CR86","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/S0021-9258(19)50651-2","volume":"25;267","author":"EH Olender","year":"1992","unstructured":"Olender EH, Simon RD (1992) The intracellular targeting and membrane topology of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 25;267(6):4223\u20134235","journal-title":"J Biol Chem"},{"issue":"12","key":"8513_CR87","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J et al (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65(12):1635\u20131638","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8513_CR88","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW (1990) Antibody to signal recognition particle in polymyositis (1990). Arthritis Rheum 33(9):1361\u20131370","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8513_CR89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","volume":"249","author":"GJ Hengstman","year":"2002","unstructured":"Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG (2002) Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 249(1):69\u201375","journal-title":"J Neurol"},{"issue":"3","key":"8513_CR90","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10067-014-2512-7","volume":"34","author":"SK Basnayake","year":"2015","unstructured":"Basnayake SK, Blumbergs P, Tan JA, Roberts-Thompson PJ, Limaye V (2015) Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort. Clin Rheumatol 34(3):603\u2013608","journal-title":"Clin Rheumatol"},{"issue":"4","key":"8513_CR91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73(4):420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"8513_CR92","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","volume":"69","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Hayashi YK, KuwanaM TR, Suzuki N, Nishino I (2012) Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Arch Neurol 69(6):728\u2013732","journal-title":"Arch Neurol"},{"issue":"3","key":"8513_CR93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","volume":"40","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute (2002) ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 40(3):567\u2013572","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"8513_CR94","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62(9):2757\u20132766","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8513_CR95","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, Zachary AA (2012) Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res 64(8):1233\u20131237","journal-title":"Arthritis Care Res"},{"key":"8513_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24541","author":"V Limaye","year":"2014","unstructured":"Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S (2014) Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. doi: 10.1002\/mus.24541","journal-title":"Muscle Nerve"},{"issue":"8","key":"8513_CR97","first-page":"789","volume":"21;359","author":"E Link","year":"2008","unstructured":"SEARCH Collaborative Group, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R (2008) SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med 21;359(8):789\u2013799","journal-title":"N Engl J Med"},{"issue":"2","key":"8513_CR98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","volume":"41","author":"P Grable-Esposito","year":"2010","unstructured":"Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA (2010) Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 41(2):185\u2013190","journal-title":"Muscle Nerve"},{"issue":"12","key":"8513_CR99","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","volume":"64","author":"JL Werner","year":"2012","unstructured":"Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL (2012) Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum 64(12):4087\u20134093","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8513_CR100","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP (2007) Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 56(9):3125\u20133131","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8513_CR101","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23(3):496\u2013502","journal-title":"Mod Rheumatol"},{"key":"8513_CR102","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","volume":"51","author":"Y Muro","year":"2012","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M (2012) Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission. Rheumatology 51:800\u2013804","journal-title":"Rheumatology"},{"issue":"1","key":"8513_CR103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u2013232","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8513_CR104","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T et al (2010) The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49(3):433\u2013440","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8513_CR105","first-page":"CD003643","volume":"15","author":"PA Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE, Choy EH (2012) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 15(8):CD003643","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"8513_CR106","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","volume":"46","author":"Y Yamasaki","year":"2007","unstructured":"Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S et al (2007) Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis. Rheumatology 46(1):124\u2013130","journal-title":"Rheumatology"},{"issue":"10","key":"8513_CR107","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","volume":"62","author":"PA Morganroth","year":"2010","unstructured":"Morganroth PA, Kreider ME, Werth VP (2010) Mycophenolate mofetil for interstitial lung disease in dermatomyositis. Arthritis Care Res 62(10):1496\u20131501","journal-title":"Arthritis Care Res"},{"issue":"5","key":"8513_CR108","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","volume":"40","author":"A Fischer","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER et al (2013) Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol 40(5):640\u2013646","journal-title":"J Rheumatol"},{"issue":"8","key":"8513_CR109","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"MR Wilkes","year":"2005","unstructured":"Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52(8):2439\u20132446","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8513_CR110","first-page":"436","volume":"31","author":"A Labirua-Iturburu","year":"2013","unstructured":"Labirua-Iturburu A, Selva-O\u2019Callaghan A, Mart\u00ednez-G\u00f3mez X, Trallero-Aragu\u00e1s E, Labrador-Horrillo M, Vilardell-Tarr\u00e9s M (2013) Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol 31(3):436\u2013439","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"8513_CR111","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3899\/jrheum.121026","volume":"40","author":"L Cavagna","year":"2013","unstructured":"Cavagna L, Caporali R, Abd\u00ec-Al\u00ec L, Dore R, Meloni F, Montecucco C (2013) Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease. J Rheumatol 40(4):484\u2013492","journal-title":"J Rheumatol"},{"issue":"1","key":"8513_CR112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203314554849","volume":"24","author":"T Kurita","year":"2015","unstructured":"Kurita T, Yasuda S, Amengual O, Atsumi T (2015) The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis\/dermatomyositis. Lupus 24(1):3\u20139","journal-title":"Lupus"},{"issue":"3","key":"8513_CR113","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-012-2142-x","volume":"32","author":"Y Muro","year":"2013","unstructured":"Muro Y, Sugiura K, Akiyama M (2013) Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Clin Rheumatol 32(3):395\u2013398","journal-title":"Clin Rheumatol"},{"issue":"5","key":"8513_CR114","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.39.428","volume":"39","author":"F Tanaka","year":"2000","unstructured":"Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, Eguchi K (2000) Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Intern Med 39(5):428\u2013430","journal-title":"Intern Med"},{"issue":"9","key":"8513_CR115","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32(9):1719\u20131726","journal-title":"J Rheumatol"},{"issue":"2","key":"8513_CR116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52(2):601\u2013607","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8513_CR117","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L (2010) Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res 62(9):1328\u20131334","journal-title":"Arthritis Care Res"},{"issue":"12","key":"8513_CR118","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/rheumatology\/ker305","volume":"50","author":"M Couderc","year":"2011","unstructured":"Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O et al (2011) Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology 50(12):2283\u20132289","journal-title":"Rheumatology"},{"issue":"7","key":"8513_CR119","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","volume":"38","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Decaluwe H, Barnerias C, Gherardi R, Quartier P, Faye A et al (2011) Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry. J Rheumatol 38(7):1436\u20131440","journal-title":"J Rheumatol"},{"issue":"12","key":"8513_CR120","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","volume":"50","author":"EA Mahler","year":"2011","unstructured":"Mahler EA, Blom M, Voermans NC, van Engelen BG, van Riel PL, Vonk MC (2011) Rituximab treatment in patients with refractory inflammatory myopathies. Rheumatology 50(12):2206\u20132213","journal-title":"Rheumatology"},{"issue":"2","key":"8513_CR121","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65(2):314\u2013324","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8513_CR122","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","volume":"66","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM (2014) Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis Rheum 66(3):740\u2013749","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8513_CR123","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rmed.2012.01.001","volume":"106","author":"I Marie","year":"2012","unstructured":"Marie I, Dominique S, Janvresse A, Levesque H, Menard JF (2012) Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med 106(4):581\u2013587","journal-title":"Respir Med"},{"issue":"4","key":"8513_CR124","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000346573","volume":"225","author":"A Clottu","year":"2012","unstructured":"Clottu A, Laffitte E, Prins C, Chizzolini C (2012) Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis. Dermatology 225(4):376\u2013380","journal-title":"Dermatology"},{"issue":"2\u20133","key":"8513_CR125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12026-013-8408-9","volume":"56","author":"L Nalotto","year":"2013","unstructured":"Nalotto L, Iaccarino L, Zen M, Gatto M, Borella E, Domenighetti M, Punzi L, Doria A (2013) Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature. Immunol Res 56(2\u20133):362\u2013370","journal-title":"Immunol Res"},{"issue":"6","key":"8513_CR126","first-page":"896","volume":"31","author":"F Mu\u00f1oz-Beamud","year":"2014","unstructured":"Mu\u00f1oz-Beamud F, Isenberg DA (2014) Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies. Clin Exp Rheumatol 31(6):896\u2013903","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"8513_CR127","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/rheumatology\/keu024","volume":"53","author":"L Unger","year":"2014","unstructured":"Unger L, Kampf S, L\u00fcthke K, Aringer M (2014) Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population. Rheumatology 53(9):1630\u20131638","journal-title":"Rheumatology"},{"key":"8513_CR128","doi-asserted-by":"crossref","unstructured":"Andersson H, Sem M, Lund MB, Aal\u00f8kken TM, G\u00fcnther A, Walle-Hansen R, Garen T (2015) Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease. Rheumatology","DOI":"10.1093\/rheumatology\/kev004"},{"key":"8513_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14397595.2015.1014140","volume":"12","author":"Y Koichi","year":"2015","unstructured":"Koichi Y, Aya Y, Megumi U, Shunichi K, Masafumi S, Hiroaki M et al (2015) A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment. Mod Rheumatol 12:1\u20135","journal-title":"Mod Rheumatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8513-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8513-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:45:53Z","timestamp":1718127953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8513-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,9]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8513"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8513-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,9]]}}}